Baxter International Inc
Change company Symbol lookup
Select an option...
BAX Baxter International Inc
VTRS Viatris Inc
CCI Crown Castle International Corp
PTON Peloton Interactive Inc
ETSY ETSY Inc
SNAP Snap Inc
TWLO Twilio Inc
CHWY Chewy Inc
WOOF Petco Health and Wellness Company Inc
TEAM Atlassian Corporation PLC
Go

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Postmarket

Last Trade
Delayed
$83.58
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$83.58
Day's Change
-2.91 (-3.36%)
Bid
--
Ask
--
B/A Size
--
Day's High
86.76
Day's Low
83.54
Volume
(Heavy Day)
Volume:
4,241,231

10-day average volume:
2,417,105
4,241,231

Company Profile

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Valuation Ratios

Price/Earnings (TTM)
41.82x
Price/Sales (TTM)
3.69x
Price/Book (MRQ)
5.15x
Price/Cash Flow (TTM)
22.71x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

April 2021
Current Month
9.0M
Previous Month
8.9M
Percent of Float
1.78%
Days to Cover
5.3290 Days

Share Information

BAX is in a share class of common stock
Float
497.7M
Shares Outstanding
502.9M
Institutions Holding Shares
1,445
88.04%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Jose E. AlmeidaChmn.
  • James K. SaccaroCFO
  • Sean B. W. MartinSr.VP
  • Jeanne K. MasonSr.VP
  • Giuseppe AccogliSr.VP

Address

Insider Trading

During the most recent quarter, 21K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.